Suicide Clinical Trial
Official title:
Clarifying the Endocrinology of Acute Risk 4 (CLEAR-4): Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality
This within-person, crossover, 2-condition, placebo-controlled study compares the impact of two perimenstrual conditions on severity of suicidal symptoms in females with past-month suicidality but minimal risk of imminent suicide attempt. The two conditions are (1) perimenstrual administration of estradiol and (2) natural perimenstrual withdrawal from estradiol during placebo.
Previous work from our group demonstrates that perimenstrual worsening of suicidal thoughts in females is caused by normal perimenstrual withdrawal from the ovarian steroid estradiol (E2), since perimenstrual administration of E2+P4 or E2 alone prevented the perimenstrual worsening of suicidal ideation observed under placebo. In the present study, we follow up on that work with an additional mechanistic crossover trial in which E2 will be administered perimenstrually (E2 condition) or not (PBO condition) and neurocognitive mechanisms of suicidal symptom improvement will be probed. 50 (30 completers) female outpatients, with past-month suicidal ideation but minimal imminent risk for attempt, will complete self-reports and clinical interviews measuring the presence and severity of suicidal ideation in each of two conditions (A, B: order randomized across two menstrual cycles): (A) perimenstrual E2 withdrawal/depletion (under placebo), (B) perimenstrual administration of E2. A washout cycle will separate conditions. Analyses will compare the perimenstrual trajectories of symptoms and suicidality across the two conditions. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04127292 -
Impact of Clinician Virtual Human Interaction Training in Emotional Self-Awareness on Patients Suicidal Ideation and Suicide Crisis Syndrome
|
N/A | |
| Recruiting |
NCT06079853 -
Nurse Suicide: Physiologic Sleep Health Promotion Trial
|
N/A | |
| Recruiting |
NCT05423483 -
Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents
|
Phase 2 | |
| Completed |
NCT03272048 -
Identifying Effective Approaches to Counseling on Firearm Safety
|
N/A | |
| Completed |
NCT05514587 -
Meaning of Life Questionnaire (MLQ) in Patients Admitted to the Crisis Centre (MSVCAC)
|
||
| Enrolling by invitation |
NCT05639426 -
Preventing Youth Violence Through Building Equitable Communities
|
N/A | |
| Completed |
NCT03703128 -
Suicide in People Aged 45-60: A Case-control Psychological Autopsy Study
|
||
| Completed |
NCT03646903 -
Reducing Help-Seeking Stigma in Young Adults at Elevated Suicide Risk
|
N/A | |
| Not yet recruiting |
NCT06349915 -
A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents
|
N/A | |
| Not yet recruiting |
NCT05558332 -
Youth Nominated Support Team
|
N/A | |
| Completed |
NCT02718248 -
Ottawa Suicide Prevention in Men Pilot Study
|
N/A | |
| Completed |
NCT02094898 -
Ketamine for Depression and Suicide Risk
|
Phase 2 | |
| Completed |
NCT01594138 -
Linguistic Characteristics of Suicidal Patients in the Emergency Department
|
N/A | |
| Completed |
NCT01360736 -
A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)
|
N/A | |
| Completed |
NCT02228044 -
Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment
|
N/A | |
| Completed |
NCT00604097 -
Preventing Youth Suicide in Primary Care: A Family Model
|
Phase 3 | |
| Completed |
NCT00387855 -
An Evaluation of the SOS (Suicide Prevention) Program
|
N/A | |
| Recruiting |
NCT03519802 -
Evaluation of Cognitive Function in a Suicidal Crisis
|
||
| Completed |
NCT05580757 -
Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
|
||
| Recruiting |
NCT03030924 -
Wearable Suicidal Early Warning System for Adolescents
|